This Cutting-Edge Psychedelics and Cannabis Company Is Positioned to Dominate the Global Mental Health Market
by MF WILLIAMS
MARCH 8, 2021
For over two years now, the FDA has been fast-tracking psilocybin for treatment of PTSD.
Psychedelic pharmaceuticals coupled with pharmaceutical cannabis is now projected to grow at an astonishing 30-fold growth rate approaching $60 billion this decade!
Click for Full Text!
A great many of our veterans suffer from PTSD.
When we were working Security at Woodstock 94 some guy made an announcement, "Don't eat the green dots." It was bad acid and people were freaking out. :-O